Global Antimicrobial Resistance: Strategies and Challenges
Antimicrobial Resistance: Strategies and Challenges
DOI:
https://doi.org/10.54393/mjz.v6i1.146Keywords:
Antibiotics, Antimicrobial, Bacteria Mechanism, ResistanceAbstract
Antimicrobial resistance (AMR) is a critical health challenge worldwide, that arises when bacteria, viruses, fungi, and parasites become resistant to antimicrobial medications, making diseases more challenging to treat. The enzymatic breakdown of antibiotics, modifications to target locations, elevated efflux pumps, and changes in cell membrane permeability are some of the processes behind AMR. A key factor behind the development and transmission of AMR has been the unregulated use of livestock feed for preventive purposes. Rapid global expansion of antibiotic-resistant bacteria is posing a hidden pandemic risk to public health and demanding immediate action. The misuse and unnecessary overreliance on antibiotics in human medicine is one of the many contributing factors of AMR, veterinary practices, and agriculture, as well as inadequate infection prevention strategies, lack of diagnostic tools, and inadequate sanitation. Preventive measures against AMR involve promoting the rational use of antibiotics through antimicrobial stewardship, improving infection control practices, advancing rapid diagnostic technologies, reducing antibiotic use in food production, and increasing public awareness. Efforts must also focus on global collaboration to monitor resistance trends, enhance regulatory frameworks, and invest in research to develop novel antimicrobial agents and alternative therapies. Addressing AMR requires an interdisciplinary and coordinated approach to safeguard the efficacy of current antimicrobial treatments and reduce the occurrence of resistance.
References
Aijaz M, Ahmad M, Ansari MA, Ahmad S. Antimicrobial Resistance in A Globalized World: Current Challenges and Future Perspectives. International Journal of Pharmaceutical Drug Design. 2023; 1(1): 7-22.
Bennani H, Mateus A, Mays N, Eastmure E, Stärk KD, Häsler B. Overview of Evidence of Antimicrobial Use and Antimicrobial Resistance in the Food Chain. Antibiotics. 2020 Jan; 9(2): 49. doi: 10.3390/antibiotics9020049.
Pruntova OV, Russaleyev VS, Shadrova NB. Current Understanding of Antimicrobial Resistance Mechanisms in Bacteria (Analytical Review). Veterinary Science Today. 2022; 11(1): 7-13. doi: 10.29326/2304-196X-2022-11-1-7-13.
Khameneh B, Diab R, Ghazvini K, Bazzaz BS. Breakthroughs in Bacterial Resistance Mechanisms and the Potential Ways to Combat Them. Microbial Pathogenesis. 2016 Jun; 95: 32-42. doi: 10.1016/j.micpath.2016.02.009.
Zhou G, Shi QS, Huang XM, Xie XB. The Three Bacterial Lines of Defense Against Antimicrobial Agents. International Journal of Molecular Sciences. 2015 Sep; 16(9): 21711-33. doi: 10.3390/ijms160921711.
Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA et al. Antimicrobial Resistance: Impacts, Challenges, and Future Prospects. Journal of Medicine, Surgery, and Public Health. 2024 Apr; 2: 100081. doi: 10.1016/j.glmedi.2024.100081.
Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA et al. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. In Healthcare. 2023 Jan; 11(13): 1946. doi: 10.3390/healthcare11131946.
Alam MM, Islam M, Wahab A, Billah M. Antimicrobial Resistance Crisis and Combating Approaches. Journal of Medicine. 2019 Jan; 20(1): 38-45. doi: 10.3329/jom.v20i1.38842.
Allel K, Day L, Hamilton A, Lin L, Furuya-Kanamori L, Moore CE et al. Global Antimicrobial-Resistance Drivers: An Ecological Country-Level Study at the Human–Animal Interface. The Lancet Planetary Health. 2023 Apr; 7(4): e291-303. doi: 10.1016/S2542-5196(23)00026-8.
Hansson K and Brenthel A. Imagining A Post-Antibiotic Era: A Cultural Analysis of Crisis and Antibiotic Resistance. Medical Humanities. 2022 Sep; 48(3): 381-8. doi: 10.1136/medhum-2022-012409.
Van Duijkeren E, Schink AK, Roberts MC, Wang Y, Schwarz S. Mechanisms of Bacterial Resistance to Antimicrobial Agents. Antimicrobial Resistance in Bacteria from Livestock and Companion Animals. 2018 Oct: 51-82. doi: 10.1128/9781555819804.ch4.
Drlica K and Zhao X. Bacterial Death from Treatment with Fluoroquinolones and Other Lethal Stressors. Expert Review of Anti-Infective Therapy. 2021 May; 19(5): 601-18. doi: 10.1080/14787210.2021.1840353.
Varela MF, Stephen J, Lekshmi M, Ojha M, Wenzel N, Sanford LM et al. Bacterial Resistance to Antimicrobial Agents. Antibiotics. 2021 May; 10(5): 593. doi: 10.3390/antibiotics10050593.
Petri WA. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th. New York: McGraw-Hill. 2011: 1463-76. doi:
Guan D, Li J, Chen F, Li J, Bian X, Yu Y et al. A Facile and Selective Derivatization Approach On Kynurenine-NH2 in Daptomycin, leading to the Discovery of Hexakynomycin to Combat Multidrug-Resistant Gram-Positive Pathogens Especially Daptomycin-Resistant Bacteria. European Journal of Medicinal Chemistry. 2023 Nov; 259: 115638. doi: 10.1016/j.ejmech.2023.115638.
Walsh TR, Gales AC, Laxminarayan R, Dodd PC. Antimicrobial Resistance: Addressing A Global Threat to Humanity. Plos Medicine. 2023 Jul; 20(7): e1004264. doi: 10.1371/journal.pmed.1004264.
Kakoullis L, Papachristodoulou E, Chra P, Panos G. Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions. Antibiotics. 2021 Apr; 10(4): 415. doi: 10.3390/antibiotics10040415.
Reygaert WC. An Overview of the Antimicrobial Resistance Mechanisms of Bacteria. AIMS Microbiology. 2018 Jun; 4(3): 482. doi: 10.3934/microbiol.2018.3.482.
Huang L, Wu C, Gao H, Xu C, Dai M, Huang L et al. Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview. Antibiotics. 2022 Apr; 11(4): 520. doi: 10.3390/antibiotics11040520.
Ashley RE, Dittmore A, McPherson SA, Turnbough Jr CL, Neuman KC, Osheroff N. Activities of Gyrase and Topoisomerase IV On Positively Supercoiled DNA. Nucleic Acids Research. 2017 Sep; 45(16): 9611-24. doi: 10.1093/nar/gkx649.
Saha M and Sarkar A. Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century. Journal of Xenobiotics. 2021 Dec; 11(4): 197-214. doi: 10.3390/jox11040013.
Foster TJ. Antibiotic Resistance in Staphylococcus Aureus. Current Status and Future Prospects. Federation of European Microbiological Societies Microbiology Reviews. 2017 Mar; 41(3): 430-49. doi: 10.1093/femsre/fux007.
Omwenga I, Aboge GO, Mitema ES, Obiero G, Ngaywa C, Ngwili N et al. Antimicrobial Usage and Detection of Multidrug-Resistant Staphylococcus Aureus, Including Methicillin-Resistant Strains in Raw Milk of Livestock from Northern Kenya. Microbial Drug Resistance. 2021 Jun; 27(6): 843-54. doi: 10.1089/mdr.2020.0252.
Choi U and Lee CR. Distinct Roles of Outer Membrane Porins in Antibiotic Resistance and Membrane Integrity in Escherichia Coli. Frontiers in Microbiology. 2019 Apr; 10: 953. doi: 10.3389/fmicb.2019.00953.
Ghai I and Ghai S. Understanding Antibiotic Resistance Via Outer Membrane Permeability. Infection and Drug Resistance. 2018 Apr: 523-30. doi: 10.2147/IDR.S156995.
Dutt Y, Dhiman R, Singh T, Vibhuti A, Gupta A, Pandey RP et al. The Association Between Biofilm Formation and Antimicrobial Resistance with Possible Ingenious Bio-Remedial Approaches. Antibiotics. 2022 Jul; 11(7): 930. doi: 10.3390/antibiotics11070930.
Almatroudi A. Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts. Biology. 2025 Feb; 14(2): 165. doi: 10.3390/biology14020165.
Thacharodi A, Lamont IL. Aminoglycoside Resistance in Pseudomonas aeruginosa: The Contribution of the MexXY-OprM Efflux Pump Varies Between Isolates. Journal of Medical Microbiology. 2022 Jun; 71(6): 001551. doi: 10.1099/jmm.0.001551.
Arce-Rodríguez A, Pankratz D, Preusse M, Nikel PI, Häussler S. Dual Effect: High NADH Levels Contribute to Efflux-Mediated Antibiotic Resistance but Drive Lethality Mediated by Reactive Oxygen Species. Master of Bioscience. 2022 Feb; 13(1): e02434-21. doi: 10.1128/mbio.02434-21.
Davin-Regli A, Pages JM, Ferrand A. Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria. Antibiotics. 2021 Sep; 10(9): 1117. doi: 10.3390/antibiotics10091117.
Dostál L, Shao S, Schildbach JF. Tracking F Plasmid Tral Relaxase Processing Reactions Provides Insight into F Plasmid Transfer. Nucleic Acids Research. 2011 Apr; 39(7): 2658-70. doi: 10.1093/nar/gkq1137.
Wong JJ, Lu J, Glover JM. Relaxosome Function and Conjugation Regulation in F‐Like Plasmids–A Structural Biology Perspective. Molecular Microbiology. 2012 Aug; 85(4): 602-17. doi: 10.1111/j.1365-2958.2012.08131.x.
Lai CK, Ng RW, Leung SS, Hui M, Ip M. Overcoming the Rising Incidence and Evolving Mechanisms of Antibiotic Resistance by Novel Drug Delivery Approaches–An Overview. Advanced Drug Delivery Reviews. 2022 Feb; 181: 114078. doi: 10.1016/j.addr.2021.114078.
Wallis D, Coatsworth JD, Mennis J, Riggs NR, Zaharakis N, Russell MA et al. Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International Journal of Environmental Research and Public Health. 2022 Feb; 19(3): 1850. doi: 10.3390/ijerph19031850.
Aggarwal R, Mahajan P, Pandiya S, Bajaj A, Verma SK, Yadav P et al. Antibiotic Resistance: A Global Crisis, Problems and Solutions. Critical Reviews in Microbiology. 2024 Sep; 50(5): 896-921. doi: 10.1080/1040841X.2024.2313024.
Sahebrao NU and Navnath NS. A Review on Antibiotic Resistance: Alarm Bells Are Ringing. Research Journal of Science and Technology. 2024 Dec; 16(4): 313-6. doi: 10.52711/2349-2988.2024.00045.
Zewdie S, Kassa AA, Yayehrad AT, Bizuneh MM, Ayenew W, Zewudie M et al. Non-Prescription Antibiotic Use and Its Predictors Among Children in Low-And Middle-Income Countries: A Systematic Review and Meta-Analysis. Italian Journal of Pediatrics. 2024 Dec; 50(1): 260. doi: 10.1186/s13052-024-01808-5.
Vidal AG, Alibayov B, Frame IJ, Murin L, Creel A, Hu D et al. Induction of the Macrolide-Resistance Efflux Pump Mega Inhibits Intoxication of Staphylococcus Aureus Strains By Streptococcus Pneumonia. Microbiological Research. 2022 Oct; 263: 127134. doi: 10.1016/j.micres.2022.127134.
Yao T, Liu Z, Li T, Zhang H, Liu J, Li H et al. Characterization of the Biosynthetic Gene Cluster of the Polyene Macrolide Antibiotic Reedsmycins from A Marine-Derived Streptomyces Strain. Microbial Cell Factories. 2018 Dec; 17: 1-2. doi: 10.1186/s12934-018-0943-6.
Vilches CA, Hernandez CE, Mendez C, Salas JA. Role of Glycosylation and De-glycosylation in Biosynthesis of and Resistance to Oleandomycin in the Producer Organism, Streptomyces Antibioticus. Journal of Bacteriology. 1992 Jan; 174(1): 161-5. doi: 10.1128/jb.174.1.161-165.1992.
Wicha SG, Märtson AG, Nielsen EI, Koch BC, Friberg LE, Alffenaar JW et al. From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics. Clinical Pharmacology and Therapeutics. 2021 Apr; 109(4): 928-41. doi: 10.1002/cpt.2202.
Haas W, Singh N, Lainhart W, Mingle L, Nazarian E, Mitchell K et al. Genomic Analysis of Vancomycin-Resistant Staphylococcus Aureus Isolates from the 3rd Case Identified in the United States Reveals Chromosomal Integration of the Vana Locus. Microbiology Spectrum. 2023 Apr; 11(2): e04317-22. doi: 10.1128/spectrum.04317-22.
Vo T, Pontarotti P, Rolain JM, Merhej V. Mechanisms of Acquisition of the Vana Operon Among Vancomycin-Resistant Staphylococcus Aureus Genomes: The Tip of the Iceberg? International Journal of Antimicrobial Agents. 2024 Jun; 63(6): 107154. doi: 10.1016/j.ijantimicag.2024.107154.
Jiang Y, Lin W, Tan S, Wang Y, Wu W, Lu Z. Synthesis and Antibacterial Evaluation of Novel Vancomycin Derivatives Containing Quaternary Ammonium Moieties. American Chemical Society Omega. 2023 Jul; 8(31): 28511-8. doi: 10.1021/acsomega.3c02879.
Maus CE, Plikaytis BB, Shinnick TM. Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium Tuberculosis. Antimicrobial Agents and Chemotherapy. 2005 Aug; 49(8): 3192-7. doi: 10.1128/AAC.49.8.3192-3197.2005.
Sellera FP, Fuentes-Castillo D, Furlan JP. One Health Spread of 16S Ribosomal RNA Methyl-Transferase-Harboring Gram-Negative Bacterial Genomes: An Overview of the Americas. Pathogens. 2023 Sep; 12(9): 1164. doi: 10.3390/pathogens12091164.
Abushaheen MA, Fatani AJ, Alosaimi M, Mansy W, George M, Acharya S et al. Antimicrobial Resistance, Mechanisms and Its Clinical Significance. Disease-A-Month. 2020 Jun; 66(6): 100971. doi: 10.1016/j.disamonth.2020.100971.
Mo Y, Oonsivilai M, Lim C, Niehus R, Cooper BS. Implications of Reducing Antibiotic Treatment Duration for Antimicrobial Resistance in Hospital Settings: A Modelling Study and Meta-Analysis. Plos Medicine. 2023 Jun; 20(6): e1004013. doi: 10.1371/journal.pmed.1004013.
Young EH, Strey KA, Lee GC, Carlson TJ, Koeller JM, Mendoza VM et al. National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016. Antibiotics. 2022 Dec; 12(1): 51. doi: 10.3390/antibiotics12010051.
Hwang S and Kwon KT. Core Elements for Successful Implementation of Antimicrobial Stewardship Programs. Infection and Chemotherapy. 2021 Sep; 53(3): 421. doi: 10.3947/ic.2021.0093.
Pinto Ferreira J, Battaglia D, Dorado García A, Tempelman K, Bullon C, Motriuc N et al. Achieving Antimicrobial Stewardship On the Global Scale: Challenges and Opportunities. Microorganisms. 2022 Aug; 10(8): 1599. doi: 10.3390/microorganisms10081599.
Stephens LJ, Werrett MV, Sedgwick AC, Bull SD, Andrews PC. Antimicrobial Innovation: A Current Update and Perspective On the Antibiotic Drug Development Pipeline. Future Medicinal Chemistry. 2020 Nov; 12(22): 2035-65. doi: 10.4155/fmc-2020-0225.
Brüssow H. The Antibiotic Resistance Crisis and the Development of New Antibiotics. Microbial Biotechnology. 2024 Jul;17(7): e14510. doi: 10.1111/1751-7915.14510.
Cohen CC, Dick AW, Agarwal M, Gracner T, Mitchell S, Stone PW. Trends in Antibiotics Use Among Long-Term US Nursing-Home Residents. Infection Control and Hospital Epidemiology. 2021 Mar; 42(3): 311-7. doi: 10.1017/ice.2020.422.
Adebisi YA. Balancing the Risks and Benefits of Antibiotic Use in A Globalized World: The Ethics of Antimicrobial Resistance. Globalization and Health. 2023 Apr; 19(1): 27. doi: 10.1186/s12992-023-00930-z.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MARKHOR (The Journal of Zoology)

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@markhorjournal.com